Drug application
LENVATINIB (LENVATINIB MESYLATE)
Drugs@FDA ANDA 213092 · SUN PHARM INDS INC
Key facts
| Drug name | LENVATINIB |
|---|---|
| Active ingredients | LENVATINIB MESYLATE |
| Application type | ANDA |
| Application number | 213092 |
| Company | SUN PHARM INDS INC |
| Dosage forms | CAPSULE, ORAL |
| Strength | 4MG |
| Marketing status | Prescription |
| Reference listed drug | No |
| Latest submission status date | Mar 1, 2022 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
- Yes FDA letters on file
- No FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: